Slonin Jonathan
Officer at PCRX
- Sold, on record
- $628k
- Dollars the filings state
- Form 4 sales
- 11
- Latest Aug 17, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PCRXPacira BioSciences, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice PCRXNoticeJan 6, 2025 2025
Filed to sell 879 shares ($16k)
Slonin Jonathan, Officer
10b5-1 plan0.5x usual sizeFiling
- 2 Form 4 sale PCRXRoutineJan 6, 2025 same day
Sold 879 shares at $18.40 ($16k)
Slonin Jonathan, Chief Medical Officer
10b5-1 planSold 0.9% of holdings ($1.7M position)93,444 shares left0.5x usual sizeFollows a Form 144Filing
- 3 Form 144 notice PCRXNoticeNov 17, 2025 +315 days
Filed to sell 3,960 shares ($95k)
Slonin Jonathan, Officer
10b5-1 plan2.1x usual sizeFiling
- 4 Form 4 sale PCRXRoutineNov 17, 2025 same day
Sold 3,960 shares at $24.09 ($95k)
Slonin Jonathan, Chief Medical Officer
10b5-1 planSold 2.2% of holdings ($4.4M position)178,367 shares left2.1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice PCRXNoticeMar 17, 2026 +120 days
Filed to sell 3,261 shares ($74k)
Slonin Jonathan, Officer
10b5-1 plan1.1x usual sizeFiling
- 6 Form 4 sale PCRXRoutineMar 17, 2026 same day
Sold 3,261 shares at $22.82 ($74k)
Slonin Jonathan, Chief Medical Officer
10b5-1 planSold 1.4% of holdings ($5.2M position)223,640 shares left1.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice PCRXNoticeAug 17, 2026 +153 days
Filed to sell 3,040 shares ($71k)
Slonin Jonathan, Officer
10b5-1 plan0.9x usual sizeFiling
- 8 Form 4 sale PCRXRoutineAug 17, 2026 same day
Sold 3,040 shares at $23.23 ($71k)
Slonin Jonathan, Chief Medical Officer
10b5-1 planSold 1.4% of holdings ($5.1M position)216,384 shares left0.9x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 18, 2026 | PCRX | Chief Medical Officer | Form 4 sale | 3,040 | $71k | 1.4% | Routine | SEC |
| Aug 17, 2026 | Aug 17, 2026 | PCRX | Officer | Form 144 notice | 3,040 | $71k | Notice | SEC | |
| Mar 17, 2026 | Mar 19, 2026 | PCRX | Chief Medical Officer | Form 4 sale | 3,261 | $74k | 1.4% | Routine | SEC |
| Mar 17, 2026 | Mar 17, 2026 | PCRX | Officer | Form 144 notice | 3,261 | $74k | Notice | SEC | |
| Nov 17, 2025 | Nov 19, 2025 | PCRX | Chief Medical Officer | Form 4 sale | 3,960 | $95k | 2.2% | Routine | SEC |
| Nov 17, 2025 | Nov 17, 2025 | PCRX | Officer | Form 144 notice | 3,960 | $95k | Notice | SEC | |
| Jan 6, 2025 | Jan 6, 2025 | PCRX | Chief Medical Officer | Form 4 sale | 879 | $16k | 0.9% | Routine | SEC |
| Jan 6, 2025 | Jan 6, 2025 | PCRX | Officer | Form 144 notice | 879 | $16k | Notice | SEC | |
| Aug 2, 2024 | Aug 2, 2024 | PCRX | Chief Medical Officer | Form 4 sale | 945 | $19k | 1.0% | Routine | SEC |
| Aug 2, 2024 | Aug 2, 2024 | PCRX | Officer | Form 144 notice | 945 | $19k | Notice | SEC | |
| Jul 2, 2024 | Jul 3, 2024 | PCRX | Chief Medical Officer | Form 4 sale | 2,836 | $80k | 2.9% | Unusual | SEC |
| Jul 2, 2024 | Jul 2, 2024 | PCRX | Officer | Form 144 notice | 2,836 | $80k | Notice | SEC | |
| Jun 11, 2024 | Jun 13, 2024 | PCRX | Chief Medical Officer | Form 4 sale | 5,012 | $143k | 10.1% | Unusual | SEC |
| Jun 11, 2024 | Jun 11, 2024 | PCRX | Officer | Form 144 notice | 5,012 | $143k | Notice | SEC | |
| Jun 7, 2023 | Jun 7, 2023 | PCRX | Officer | Form 144 notice | 490 | $19k | Notice | SEC | |
| Jun 7, 2023 | Jun 7, 2023 | PCRX | Chief Clinical Officer | Form 4 sale | 961 | $37k | 2.6% | No plan | SEC |
| Jun 6, 2023 | Jun 6, 2023 | PCRX | Officer | Form 144 notice | 471 | $18k | Notice | SEC | |
| Aug 3, 2022 | Aug 5, 2022 | PCRX | Chief Clinical Officer | Form 4 sale | 308 | $17k | 0.8% | Plan not stated | SEC |
| Jul 5, 2022 | Jul 7, 2022 | PCRX | Chief Clinical Officer | Form 4 sale | 924 | $53k | 2.4% | Plan not stated | SEC |
| Jun 6, 2022 | Jun 8, 2022 | PCRX | Chief Clinical Officer | Form 4 sale | 362 | $22k | 1.3% | Plan not stated | SEC |